Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €68.01 billion as of December 22, 2025. Its market cap has decreased by -12.99% in one year.

Market Cap

68.01B

Enterprise Value

54.38B

Revenue

12.14B

Ranking

n/a

PE Ratio

17.43

Stock Price

€664.40

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 68.01B, an increase of 51,651.92%. That is a compound annual growth rate of 20.54%.

Market Cap History

Date	Market Cap	% Change
Dec 22, 2025	68.01B	-8.13%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	243.17B
Siemens Aktiengesellschaft	183.73B
Allianz SE	148.10B
Deutsche Telekom AG	130.23B
Siemens Energy AG	102.77B
Rheinmetall AG	71.55B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	71.18B
Deutsche Bank Aktiengesellschaft	62.85B

Market Cap Rankings